Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 123   

Articles published

GSK 1,696.10 -3.40 (-0.20%)
price chart
Should you buy GlaxoSmithKline plc after today's results?
GlaxoSmithkline (LSE: GSK) has suffered four years of falling earnings as, along with FTSE 100 competitor AstraZeneca, it faced the loss of patents on some key drugs and a resulting increase in competition from generic alternatives.
Glaxo's Earnings Beat Estimates as New Product Sales Double  Bloomberg
GlaxoSmithKline PLC's (GSK) "Hold" Rating Reaffirmed at Shore Capital
GlaxoSmithKline PLC (NYSE:GSK)'s stock had its “hold” rating reiterated by investment analysts at Shore Capital in a research note issued to investors on Wednesday.
GlaxoSmithKline PLC (LON:GSK) Issued With 'Buy' Rating At Jefferies ...  FTSE News
Royal Bank Of Canada Decreased Stake in Glaxosmithkline Plc (NYSE:GSK) by ...  Consumer Eagle
GlaxoSmithKline plc 17.5% Potential Upside Indicated by Jefferies International
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' today by analysts at Jefferies International.
GlaxoSmithKline PLC (LON:GSK) Issued With 'Hold' Rating At Deutsche Bank  FTSE News
Mean Price Target Forecast for coming twelve months: GlaxoSmithKline PLC ...  Is stories
Footsie perks up after shot in arm from Glaxosmithkline
A strong performance by drug giant GlaxoSmithKline PLC (LON:GSK) gave a shot in the arm to London shares on Wednesday. Shares in GSK rose 25p, or 1.5%, to 1692p after it reported a 4% rise in group sales to �6.5bn.
GlaxoSmithKline plc (NYSE:GSK) To Invest $360 Million In Britain Amid Brexit ...
GlaxoSmithKline plc (NYSE:GSK) is planning to inject $360.3 million (�275 million) in three Britain-based plants following the surprising boost it experienced post-Brexit.
GlaxoSmithKline upbeat despite currency hit  Proactive Investors UK
Stock Earnings Estimates in Limelight: GlaxoSmithKline plc (ADR) (NYSE:GSK)  Post Registrar
Brace yourself for interest rate cuts with GlaxoSmithKline plc, National Grid ...
With the uncertainty from Brexit already affecting the UK economy, it's looking likely that interest rates will be cut in the near future.
Will GlaxoSmithKline plc and AstraZeneca plc continue to be Brexit winners?
AstraZeneca converts its dividends into pence on the day it posts its results and if the pound stays, low future payouts will be worth more.
Deutsche Bank AG Reaffirms Hold Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “hold” rating restated by investment analysts at Deutsche Bank AG in a research report issued on Thursday.
GlaxoSmithKline plc (GSK) Stock Rating Reaffirmed by BNP Paribas  BBNS
GlaxoSmithKline PLC retained as Hold By Deutsche Bank  Fiscal Standard
Even after recent gains, GlaxoSmithKline plc may still be undervalued!
Since the day after the vote, shares in Glaxo have increased 16.2%, outperforming the wider FTSE 100 by around 5.5% and extending year-to-date gains to 21%, excluding dividends.
GlaxoSmithKline plc (ADR) Earning Release; Here's What to Expect
The UK-based pharmaceutical company, GlaxoSmithKline plc (ADR) (NYSE:GSK), is expected to announce second quarter (2Q) earnings result on July 27.